Semax

Quick Facts

Property	Value
Category	Nootropic / Cognitive Peptide
Risk Level	Moderate/High
Administration	Intranasal or Subcutaneous
Typical Frequency	1–2 Times Daily
Estimated Half-Life	Short Plasma Half-Life / Longer Neurological Effects
Primary Research Interest	Focus / Cognition / Neuroprotection

Important Disclaimer

This material is provided strictly for educational and informational purposes related to peptide research and experimental nootropic compounds. Semax is a biologically active peptide capable of altering neurological signaling pathways including dopaminergic and neurotrophic systems. Information presented here should not be interpreted as medical advice, treatment recommendations, or encouragement of unsupervised use.

1. Intranasal Administration Protocol

Vial Size: 10 mg
Dilutant Type: BAC Water or Sterile Saline
Initial Vial Reconstitution: Add 3 mL to the peptide vial
Transfer Instructions: Withdraw the entire vial contents and transfer into a nasal spray bottle
Final Spray Bottle Dilution: Add an additional 7 mL of dilutant for a total final volume of 10 mL
Final Concentration: 1.00 mg/mL
Spray Bottle Type: Metered spray bottle delivering approximately 0.15–0.20 mL per spray

At this concentration:

• 1 spray (0.15 mL) = 0.15 mg (150 mcg)

• 1 spray (0.20 mL) = 0.20 mg (200 mcg)

• 2 sprays total (1 per nostril) ≈ 400 mcg

Typical Delivered Amount: 400 mcg (2 sprays, 1 per nostril) in the morning. Repeat in the early afternoon as needed. Avoid near bedtime.
Frequency: 1–2 times daily
Cycle Length: 2 weeks on / 2 weeks off. Do not exceed 4 weeks on in a row to avoid dopaminergic burnout.
Special Notes: Intranasal use may cause burning, dripping, sneezing, or congestion. Rotating nostrils and using lower concentrations may help. The mixture may optionally be diluted to a total of 20 mL to reduce irritation. Although recommended doses may improve focus and clarity, more is not always better. Overuse of Semax may lead to anxiety, headaches, and overstimulation similar to excessive stimulant use. Carefully follow cycling instructions.

2. Subcutaneous Administration Protocol

Vial Size: 10 mg
Dilutant Type: BAC Water
Amount of Dilutant Added: 2.5 mL
Final Concentration: 4.00 mg/mL

At this concentration:

• 400 mcg = 0.100 mL (10.0 units)

• 1000 mcg = 0.250 mL (25.0 units)

Typical Delivered Amount: 400–1000 mcg SQ in the morning upon waking
Frequency: Once daily in the morning
Cycle Length: 2 weeks on / 2 weeks off. Do not exceed 4 weeks on in a row to avoid dopaminergic burnout.
Special Notes: Subcutaneous use is considered highly experimental. There is little evidence showing that it is nearly as effective as intranasal use. Metered nasal spray bottles can easily be purchased online, and the common consensus favors the intranasal route.

3. Summary

Semax is an experimental nootropic peptide derived from an ACTH fragment and researched for cognitive enhancement, focus, stress resilience, and neuroprotective signaling.

Research interest in Semax commonly centers around memory support, mental clarity, fatigue resistance, and neurological recovery applications.

4. Mechanism of Action

Semax is believed to influence multiple neurological pathways including dopaminergic signaling, BDNF expression, and neurotrophic activity.

Potential enhancement of BDNF signaling
Dopaminergic modulation
Improved focus and cognitive clarity
Stress resilience signaling
Potential neuroprotective effects

The compound is often discussed as both a nootropic and neuroregenerative research peptide.

5. Potential Benefits

Potential focus enhancement
Improved mental clarity
Possible memory support
Enhanced stress resilience
Potential fatigue reduction
Theoretical neuroprotective support

6. Potential Risks / Side Effects

Moderate/High

Anxiety
Headaches
Overstimulation
Irritability
Nasal irritation (intranasal route)
Potential dopaminergic burnout with excessive use
Limited long-term human safety data

7. Half-Life

Semax is commonly discussed as having a relatively short circulating plasma half-life.

However, downstream neurological and neurotrophic signaling effects may persist significantly longer than measurable plasma levels.

8. Storage Information

Store refrigerated before and after reconstitution
Protect from direct light exposure
Avoid repeated freeze-thaw cycles
Maintain sterile handling practices during preparation

9. Contraindications / Warnings

Severe anxiety disorders
Use alongside strong stimulant medications
Pregnancy or breastfeeding
Severe psychiatric disorders
Known hypersensitivity to peptide compounds

10. Research References

PubMed
NIH Publications
Nootropic and neurotrophic literature
Peer-reviewed neurology journals